MACHALA, Miroslav, Jirina PROCHAZKOVA, Jirina HOFMANOVA, Lucie KRALIKOVA, Josef SLAVIK, Zuzana TYLICHOVA, Petra OVESNÁ, Alois KOZUBIK and Jan VONDRACEK. Colon Cancer and Perturbations of the Sphingolipid Metabolism. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2019, vol. 20, No 23, p. 1-14. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms20236051.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Colon Cancer and Perturbations of the Sphingolipid Metabolism
Authors MACHALA, Miroslav (203 Czech Republic, guarantor), Jirina PROCHAZKOVA (203 Czech Republic), Jirina HOFMANOVA (203 Czech Republic), Lucie KRALIKOVA (203 Czech Republic), Josef SLAVIK (203 Czech Republic), Zuzana TYLICHOVA (203 Czech Republic), Petra OVESNÁ (203 Czech Republic, belonging to the institution), Alois KOZUBIK (203 Czech Republic) and Jan VONDRACEK (203 Czech Republic).
Edition International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2019, 1422-0067.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.556
RIV identification code RIV/00216224:14110/19:00112411
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/ijms20236051
UT WoS 000504428300233
Keywords in English colorectal cancer; colon cancer cells; sphingolipid; glycosphingolipid; colon cancer (CRC) sphingolipidomics; sphingosine-1-phosphate; lactosylceramide
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 21/7/2021 10:30.
Abstract
The development and progression of colorectal cancer (CRC), a major cause of cancer-related death in the western world, is accompanied with alterations of sphingolipid (SL) composition in colon tumors. A number of enzymes involved in the SL metabolism have been found to be deregulated in human colon tumors, in experimental rodent studies, and in human colon cancer cells in vitro. Therefore, the enzymatic pathways that modulate SL levels have received a significant attention, due to their possible contribution to CRC development, or as potential therapeutic targets. Many of these enzymes are associated with an increased sphingosine-1-phosphate/ceramide ratio, which is in turn linked with increased colon cancer cell survival, proliferation and cancer progression. Nevertheless, more attention should also be paid to the more complex SLs, including specific glycosphingolipids, such as lactosylceramides, which can be also deregulated during CRC development. In this review, we focus on the potential roles of individual SLs/SL metabolism enzymes in colon cancer, as well as on the pros and cons of employing the current in vitro models of colon cancer cells for lipidomic studies investigating the SL metabolism in CRC.
PrintDisplayed: 18/7/2024 10:22